These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24511044)

  • 1. The role of lymphadenectomy in uterine sarcoma: a clinical practical approach based on retrospective analysis.
    Hoellen F; Waldmann A; Benthin S; Hanker L; Rody A; Fischer D
    Anticancer Res; 2014 Feb; 34(2):985-93. PubMed ID: 24511044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should lymphadenectomy be performed in early stage I and II sarcomas of the corpus uteri.
    Tsikouras P; Dafopoulos A; Ammari A; Dislian V; Liatsikos S; Zografou C; Dafopoulos K; Galazios G; Maroulis G; Liberis V; Teichmann AT
    J Obstet Gynaecol Res; 2011 Nov; 37(11):1588-95. PubMed ID: 21733034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.
    Nemani D; Mitra N; Guo M; Lin L
    Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of uterine sarcomas.
    Tse KY; Crawford R; Ngan HY
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lymphadenectomy in uterine leiomyosarcoma: review of the literature and recommendations for the standard surgical procedure.
    Dafopoulos A; Tsikouras P; Dimitraki M; Galazios G; Liberis V; Maroulis G; Teichmann AT
    Arch Gynecol Obstet; 2010 Sep; 282(3):293-300. PubMed ID: 20502905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of pelvic and/or para-aortic lymphadenectomy in surgical management of apparently early carcinosarcoma of uterus.
    Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Ann Surg Oncol; 2010 Mar; 17(3):861-8. PubMed ID: 19921530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma.
    Akahira J; Tokunaga H; Toyoshima M; Takano T; Nagase S; Yoshinaga K; Tase T; Wada Y; Ito K; Niikura H; Yamada H; Sato A; Sasano H; Yaegashi N
    Oncology; 2006; 71(5-6):333-40. PubMed ID: 17690557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database.
    Nasioudis D; Mastroyannis SA; Latif NA; Ko EM; Haggerty AF; Kim SH; Morgan MA; Giuntoli RL
    Surg Oncol; 2021 Sep; 38():101589. PubMed ID: 33957499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of three rare uterine neoplasms in the same surgical specimen.
    Giuliani A; Romano L; Romanzi F; Giubbolini G; Coletti G; Di Stefano N; Le'Clerc JN; Schietroma M; Carlei F; Di Stefano L
    Ann Ital Chir; 2020 Jan; 9():. PubMed ID: 32129176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sarcomas and mixed mesodermal tumors of the uterus].
    Günthert AR
    Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
    Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
    Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in uterine sarcoma.
    Gadducci A
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):783-95. PubMed ID: 21764643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma.
    Mylonas I; Schindlbeck C
    Arch Gynecol Obstet; 2012 Jan; 285(1):207-14. PubMed ID: 21538008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should all endometrioid uterine cancer patients undergo systemic lymphadenectomy?
    Wang ZQ; Wang JL; Shen DH; Li XP; Wei LH
    Eur J Surg Oncol; 2013 Apr; 39(4):344-9. PubMed ID: 23333067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and risk factors associated with uterine sarcomas and carcinosarcomas in stage I and II.
    Visnovsky J; Kudela E; Slavik P; Krkoska M; Buocik P; Szepe P; Danko J
    Neuro Endocrinol Lett; 2015; 36(8):750-7. PubMed ID: 26921575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Staging of Uterine Carcinosarcoma Using a Multiquadrant Robotic Platform.
    Dellinger TH; Wakabayashi MT; Han ES
    J Minim Invasive Gynecol; 2017; 24(4):531-532. PubMed ID: 27794476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraaortic lymph node evaluation in stage I endometrial carcinoma.
    Piver MS; Lele SB; Barlow JJ; Blumenson L
    Obstet Gynecol; 1982 Jan; 59(1):97-100. PubMed ID: 7078856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine sarcomas.
    Punnonen R; Lauslahti K; Pystynen P; Kauppila O
    Ann Chir Gynaecol Suppl; 1985; 197():11-4. PubMed ID: 3863523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.